Fibroblast growth factor 21 as an emerging treatment for nonalcoholic fatty liver disease
Cash-Pay Patients If paying out-of-pocket regardless of brand: Zepbound: $1,069/month Compounded tirzepatide: $349/month Save $720/month ($8,640/year) with compounded option Availability Considerations: Shortage Status: Both Mounjaro and Zepbound have experienced shortages: High demand exceeding manufacturing capacity No guarantee either is available at your pharmacy May need to call multiple pharmacies Wait times of weeks to months during shortages Supply is improving as of late 2025, but intermittent shortages still occur
Similar content being viewed by others Introduction Obesity is a complex, multifactorial chronic disease characterized by excess adiposity, with or without abnormal distribution or function of adipose tissue, leading to adverse effects on health
It fuels every rep, every mile, and every recovery window
GLP-1 drugs only mask this dysregulation, and when their effect is removed, their food cravings soon return